Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05755282 · ClinicalTrials.gov registry record · Phase 4
Touch and Feel Evaluation of Two Foam Hand Sanitizers
A Phase 4 study, sponsored by Medline Industries.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT05755282: Completed Phase 4 study, sponsored by Medline Industries.
NCT05755282 is a Phase 4 study that has completed, run by Medline Industries. The registered enrollment target is 46 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05755282, a Phase 4 study, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
Hand sanitizers are a standard of hygiene requirements. Hand sanitizers must be effective at reducing germ count on the hands while ideally providing emollients to moisturize the skin after use. To improve compliance with hand sanitizing protocols, hand sanitizers should provide a pleasant touch and feel experience for end users, especially for healthcare worker (HCW) users, who use these products frequently.
Primary Outcome
The user touch and feel experience of the foam hand sanitizer products evaluated by visual analog scale assessments (VAS) ranging from 0 to 100, with higher scores indicating a more favorable outcome, of healthcare workers overall satisfaction and moisturization.
Interventions
- DRUG Post-market foam alcohol-based hand sanitizer #1
- DRUG Post-market foam alcohol-based hand sanitizer #2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-04-06 |
| Est. Completion | 2023-04-12 |
| Phase | Phase 4 |
What the finished NCT05755282 record still lists
NCT05755282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Post-market foam alcohol-based hand sanitizer #1 is the first listed.
NCT05755282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05755282 about?
NCT05755282 is a clinical study titled "Touch and Feel Evaluation of Two Foam Hand Sanitizers". Hand sanitizers are a standard of hygiene requirements. Hand sanitizers must be effective at reducing germ count on the hands while ideally providing emollients to moisturize the skin after use. To improve compliance with hand sanitizing protocols, hand sanitizers should provide a pleasant touch and...
What is the current status of trial NCT05755282?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2023-04-06. Estimated completion is 2023-04-12.
What interventions are being tested in trial NCT05755282?
The interventions under investigation include: Post-market foam alcohol-based hand sanitizer #1 (DRUG), Post-market foam alcohol-based hand sanitizer #2 (DRUG).
Who is sponsoring clinical trial NCT05755282?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05755282's enrollment target sits among peer trials
46 1348th of 2000 higher than 647 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI